Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients.
paper
Cited
Public
Unavailable
- Authors
- Spitz, M R; Shi, H; Yang, F; Hudmon, K S; Jiang, H; Chamberlain, R M; Amos, C I; Wan, Y; Cinciripini, P; Hong, W K; Wu, X
- Year
- 1998
- Journal
- Journal of the National Cancer Institute
- PMID
- 9498485
- DOI
- 10.1093/jnci/90.5.358
BACKGROUND: Interindividual differences in the structure and expression of the dopamine receptor genes affect dopamine availability and may be the genetic basis for variation in vulnerability to tobacco smoking. In this study, prevalences of polymorphisms in the TaqIA allele (A1 and A2) and the TaqIB allele (B1 and B2) of the D2 dopamine receptor gene in 157 lung cancer case patients and 126 control subjects were determined to assess whether individuals homozygous or heterozygous for the less common A1 and B1 alleles are more vulnerable to nicotine addiction. METHODS: Case and control subjects were accrued from an ongoing epidemiologic study. Blood samples were collected from them and subjected to molecular genetic analyses. Subjects were interviewed to obtain relevant information. Current and former smokers were administered a questionnaire to quantify their addiction to nicotine. RESULTS: The combined B1B2 genotypes appeared to be more prevalent in ever smokers than in never smokers among case patients (30.3% versus 13.3%; two-sided P = .233) and among control subjects (30.9% and 0%; two-sided P = .02); statistically significant differences were not observed among those with A1 genotypes. Statistically significant correlations between the presence of the A1 and B1 alleles were observed (r = .73 for case subjects and r = .76 for control subjects; two-sided P<.001). Individuals with rarer genotypes reported having been substantially younger at the time of smoking initiation (statistically significant for both A1 and B1) and having attempted to quit smoking fewer times (statistically significant for only A1). CONCLUSION: Variant alleles of the D2 dopamine receptor gene may play a role in determining nicotine addiction, although the associations between the at-risk genotypes and measures of nicotine addiction were not entirely consistent.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Co-occurring risk factors for alcohol dependence and habitual smoking. | 2000 | 15986718 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Opioid-Induced Hyperalgesia and Inflammaging in the Management of Spine Pain: The Case for Genetically Directed Dopamine Homeostasis. | Lewandrowski KU et al. | — | 2025 | → |
| Single Nucleotide Polymorphisms Within <i>DRD2, COMT, and DBH</i> and Smoking Cessation: A Systematic Review Considering Genetic Differences by Ancestry and Biological Sex. | Jones SK et al. | — | 2024 | → |
| Therapeutic strategies for colorectal cancer: antitumor efficacy of dopamine D2 receptor antagonists. | Joo SH et al. | — | 2024 | → |
| Genetic influences impacting nicotine use and abuse during adolescence: Insights from human and rodent studies. | Goldberg LR et al. | — | 2022 | → |
| The dopamine D2 receptor mediates approach-avoidance tendencies in smokers. | Zlomuzica A et al. | — | 2018 | → |
| Trace Amines and Their Receptors. | Gainetdinov RR et al. | — | 2018 | → |
| Evaluation of a Novel Difficulty of Smoking Cessation Phenotype Based on Number of Quit Attempts. | Stevens VL et al. | — | 2017 | → |
| GLOBAL OPIOID EPIDEMIC: DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM<sup>™</sup>): LESSONS LEARNED FROM AMERICA. | Blum K et al. | — | 2017 | → |
| Transcriptomics and methylomics in chronic periodontitis with tobacco use: a pilot study. | Cho YD et al. | — | 2017 | → |
| What does addiction medicine expect from neuroscience? From genes and neurons to treatment responses. | Le Foll B | — | 2016 | → |
| A review of pharmacogenetic studies of substance-related disorders. | Jones JD et al. | — | 2015 | → |
| Effects of Interaction Between Dopamine D2 Receptor and Monoamine Oxidase A Genes on Smoking Status in Young Men. | Huang CL et al. | — | 2015 | → |
| Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility. | Blum K et al. | — | 2015 | → |
| Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction. | Blum K et al. | — | 2015 | → |
| The significant association of Taq1A genotypes in DRD2/ANKK1 with smoking cessation in a large-scale meta-analysis of Caucasian populations. | Ma Y et al. | — | 2015 | → |
| Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions. | Ma Y et al. | — | 2015 | → |
| Association of dopamine receptor D2 TaqI A polymorphism and cannabis use disorder in Lagos, Nigeria. | Adedeji OH et al. | — | 2014 | → |
| Effects of nicotine on emotional distraction of attentional orienting: evidence of possible moderation by dopamine type 2 receptor genotype. | Hammersley JJ et al. | — | 2013 | → |
| Impact of COMT Val 108/158 Met and DRD2 Taq1B gene polymorphisms on vulnerability to cigarette smoking of Thai males. | Suriyaprom K et al. | — | 2013 | → |
| Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence. | Vereczkei A et al. | — | 2013 | → |
| Nicotinic receptor gene variants interact with attention deficient hyperactive disorder symptoms to predict smoking trajectories from early adolescence to adulthood. | Lee CT et al. | — | 2013 | → |
| The Impact of Cigarette Quitting during Pregnancy on Other Prenatal Health Behaviors. | Wehby GL et al. | — | 2013 | → |
| The TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women. | Cameron JD et al. | — | 2013 | → |
| Tobacco-specific nitrosamine exposures in smokers and nonsmokers exposed to cigarette or waterpipe tobacco smoke. | Radwan G et al. | — | 2013 | → |
| Exploring the relationships between tobacco smoking and schizophrenia in first-degree relatives. | Ferchiou A et al. | — | 2012 | → |
| Smoking and body weight: evidence using genetic instruments. | Wehby GL et al. | — | 2012 | → |
| Tridimensional personalities and polymorphism of dopamine D2 receptor among heroin addicts. | Teh LK et al. | — | 2012 | → |
| Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential? | Blum K et al. | — | 2011 | → |
| Dopamine polymorphisms and depressive symptoms predict foods intake. Results from a nationally representative sample. | Agurs-Collins T et al. | — | 2011 | → |
| Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors. | Blum K et al. | — | 2011 | → |
| GENES AS INSTRUMENTS FOR STUDYING RISK BEHAVIOR EFFECTS: AN APPLICATION TO MATERNAL SMOKING AND OROFACIAL CLEFTS. | Wehby G et al. | — | 2011 | → |
| Brief communication: Allelic and haplotypic structure at the DRD2 locus among five North Indian caste populations. | Saraswathy KN et al. | — | 2010 | → |
| Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation. | Wang J et al. | — | 2010 | → |
| Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients. | De Ruyck K et al. | — | 2010 | → |
| Orexin and leptin are associated with nicotine craving: a link between smoking, appetite and reward. | von der Goltz C et al. | — | 2010 | → |
| Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment. | Mroziewicz M et al. | — | 2010 | → |
| Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. | Khokhar JY et al. | — | 2010 | → |
| Population-based case-control study of DRD2 gene polymorphisms and alcoholism. | Bhaskar LV et al. | — | 2010 | → |
| The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls. | Clague J et al. | — | 2010 | → |
| 5HTT polymorphisms are associated with job stress in Japanese workers. | Katsuyama H et al. | — | 2009 | → |
| Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data. | Munafò MR et al. | — | 2009 | → |
| Cancer prevention: from 1727 to milestones of the past 100 years. | Lippman SM et al. | — | 2009 | → |
| Gene-environment interactions across development: Exploring DRD2 genotype and prenatal smoking effects on self-regulation. | Wiebe SA et al. | — | 2009 | → |
| Genetic diagnostics of functional variants of the human dopamine D2 receptor gene. | Doehring A et al. | — | 2009 | → |
| [Genetic factors of alcohol-dependence]. | Pinto E et al. | — | 2009 | → |
| Genetics of dopamine receptors and drug addiction: a comprehensive review. | Le Foll B et al. | — | 2009 | → |
| Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? | Quaak M et al. | — | 2009 | → |
| Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases. | Quaak M et al. | — | 2009 | → |
| Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population. | Sieminska A et al. | — | 2009 | → |
| Interactions between genotype and depressive symptoms on obesity. | Fuemmeler BF et al. | — | 2009 | → |
| Multiple genetic tests for susceptibility to smoking do not outperform simple family history. | Gartner CE et al. | — | 2009 | → |
| Neurotransmission-related genetic polymorphisms, negative affectivity traits, and gender predict tobacco abstinence symptoms across 44 days with and without nicotine patch. | Gilbert DG et al. | — | 2009 | → |
| Nicotine dependence: biology, behavior, and treatment. | Ray R et al. | — | 2009 | → |
| Population severance in manipur at dopamine receptor D2 locus. | Saraswathy KN et al. | — | 2009 | → |
| The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study. | Styn MA et al. | — | 2009 | → |
| Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. | Blum K et al. | — | 2008 | → |
| Allelic variation and haplotype structure of the dopamine receptor gene DRD2 in nine Indian populations. | Bhaskar LV et al. | — | 2008 | → |
| Genes implicated in serotonergic and dopaminergic functioning predict BMI categories. | Fuemmeler BF et al. | — | 2008 | → |
| Neuroimaging, genetics and the treatment of nicotine addiction. | Ray R et al. | — | 2008 | → |
| Polymorphism in environment responsive genes and association with Parkinson disease. | Singh M et al. | — | 2008 | → |
| A biopsychosocial approach to examining tobacco-related health disparities among racially classified social groups. | Fernander AF et al. | — | 2007 | → |
| Association of specific haplotypes of neurotrophic tyrosine kinase receptor 2 gene (NTRK2) with vulnerability to nicotine dependence in African-Americans and European-Americans. | Beuten J et al. | — | 2007 | → |
| Cancer prevention: from public health interventions to individual tailoring. | Rennert G | — | 2007 | → |
| Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. | Saccone SF et al. | — | 2007 | → |
| Emerging issues in smoking among adolescent and adult cancer survivors: a comprehensive review. | Klosky JL et al. | — | 2007 | → |
| Genetic polymorphisms in dopamine-related genes and smoking cessation in women: a prospective cohort study. | Ton TG et al. | — | 2007 | → |
| Genetics and smoking cessation improving outcomes in smokers at risk. | Lerman CE et al. | — | 2007 | → |
| Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry. | Palomo T et al. | — | 2007 | → |
| Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. | David SP et al. | — | 2007 | → |
| Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer. | Campa D et al. | — | 2007 | → |
| Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan. | Wang TJ et al. | — | 2007 | → |
| Primary care physicians' concerns about offering a genetic test to tailor smoking cessation treatment. | Levy DE et al. | — | 2007 | → |
| Racially classified social group tobacco-related health disparities: what is the role of genetics? | Fernander AF | — | 2007 | → |
| The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms. | Robinson JD et al. | — | 2007 | → |
| Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. | Lu C et al. | — | 2006 | → |
| Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments. | Barratt DT et al. | — | 2006 | → |
| Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment. | Magro F et al. | — | 2006 | → |
| [Heritability and candidate genes in tobacco use]. | Hamdani N et al. | — | 2006 | → |
| Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence. | Dahl JP et al. | — | 2006 | → |
| Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. | Lerman C et al. | — | 2006 | → |
| The genetics of nicotine dependence: relationship to pancreatic cancer. | MacLeod SL et al. | — | 2006 | → |
| Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians. | Shields AE et al. | — | 2005 | → |
| Chemoprevention of lung cancer. | Vignot S et al. | — | 2005 | → |
| Criteria to rationalize population screening to control oral cancer. | Lavelle CL et al. | — | 2005 | → |
| Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR. | Swan GE et al. | — | 2005 | → |
| Dopamine receptor (DRD2) genotype-dependent effects of nicotine on attention and distraction during rapid visual information processing. | Gilbert DG et al. | — | 2005 | → |
| DRD2 genotypes and substance use in adolescent children of alcoholics. | Conner BT et al. | — | 2005 | → |
| Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers. | Erblich J et al. | — | 2005 | → |
| Genetic influences on smoking: a brief review. | Al Koudsi N et al. | — | 2005 | → |
| Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men. | Costa-Mallen P et al. | — | 2005 | → |
| Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking. | Caron L et al. | — | 2005 | → |
| Pharmacogenetics and nicotine addiction treatment. | Munafò MR et al. | — | 2005 | → |
| Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications. | Lentz F et al. | — | 2005 | → |
| Pharmacotherapy and pharmacogenetics of nicotine dependence. | Berrettini WH et al. | — | 2005 | → |
| Significant association of interleukin 8 -251T/A polymorphism with smoking behavior in a Japanese population. | Ito H et al. | — | 2005 | → |
| The association between the DRD2 TaqI A polymorphism and smoking cessation in response to acupuncture in Koreans. | Park HJ et al. | — | 2005 | → |
| The use of race variables in genetic studies of complex traits and the goal of reducing health disparities: a transdisciplinary perspective. | Shields AE et al. | — | 2005 | → |
| Treating tobacco dependence: state of the science and new directions. | Lerman C et al. | — | 2005 | → |
| Advances in molecular genetics and the prevention and treatment of substance misuse: Implications of association studies of the A1 allele of the D2 dopamine receptor gene. | Young RM et al. | — | 2004 | → |
| A genomic scan for habitual smoking in families of alcoholics: common and specific genetic factors in substance dependence. | Bierut LJ et al. | — | 2004 | → |
| Alcohol-related expectancies are associated with the D2 dopamine receptor and GABAA receptor beta3 subunit genes. | Young RM et al. | — | 2004 | → |
| A novel approach for assessment of cancer predisposing roles of GSTM1 and GSTT1 genes: use of putatively cancer resistant elderly tumor-free smokers as the referents. | Belogubova EV et al. | — | 2004 | → |
| Cigarette smoking and nicotine dependence. | Zbikowski SM et al. | — | 2004 | → |
| Genetic dissection methods: designs used for tests of gene-environment interaction. | Liu X et al. | — | 2004 | → |
| Genetics and drug use as a complex phenotype. | Lessov CN et al. | — | 2004 | → |
| Genetics of tobacco use. | Maserejian NN et al. | — | 2004 | → |
| Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. | Johnstone EC et al. | — | 2004 | → |
| Interacting effects of genetic predisposition and depression on adolescent smoking progression. | Audrain-McGovern J et al. | — | 2004 | → |
| Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. | Huang SY et al. | — | 2004 | → |
| Progress in searching for susceptibility loci and genes for smoking-related behaviour. | Li MD et al. | — | 2004 | → |
| Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms. | Erblich J et al. | — | 2004 | → |
| The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population. | Johnstone EC et al. | — | 2004 | → |
| Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. | Ritchie T et al. | — | 2003 | → |
| D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. | Noble EP | — | 2003 | → |
| Differential associations of sex and D2 dopamine receptor (DRD2) genotype with negative affect and other substance abuse risk markers in children of alcoholics. | Berman SM et al. | — | 2003 | → |
| Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. | Lerman C et al. | — | 2003 | → |
| Elucidating the role of genetic factors in smoking behavior and nicotine dependence. | Lerman C et al. | — | 2003 | → |
| Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation. | Swan GE et al. | — | 2003 | → |
| Ethanol consumption and DRD2 gene TaqI a polymorphism among socially drinking males. | Hallikainen T et al. | — | 2003 | → |
| Gender-specific molecular heterosis and association studies: dopamine D2 receptor gene and smoking. | Lee HS | — | 2003 | → |
| Genetic influences on smoking behavior and nicotine dependence: a review. | Yoshimasu K et al. | — | 2003 | → |
| Monoamine oxidase polymorphisms and smoking behaviour in Japanese. | Ito H et al. | — | 2003 | → |
| Applying genetic approaches to the treatment of nicotine dependence. | Lerman C et al. | — | 2002 | → |
| Association between smoking habits and dopamine receptor D2 taqI A A2 allele in Japanese males: a confirmatory study. | Hamajima N et al. | — | 2002 | → |
| Emerging ethical issues in pharmacogenomics: from research to clinical practice. | Freund CL et al. | — | 2002 | → |
| Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease. | Kelada SN et al. | — | 2002 | → |
| Molecular epidemiology of smoking and lung cancer. | Shields PG | — | 2002 | → |
| Tobacco smoking, harm reduction, and biomarkers. | Shields PG | — | 2002 | → |
| Tobacco use, cancer causation and public health impact. | Kuper H et al. | — | 2002 | → |
| Genetic determinants of alcohol addiction and metabolism: a survey in Italy. | Pastorelli R et al. | — | 2001 | → |
| New directions in the genetic mechanisms underlying nicotine addiction. | Munafò M et al. | — | 2001 | → |
| Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. | Dagher A et al. | — | 2001 | → |
| Smoking habit and interleukin lB C-31T polymorphism. | Hamajima N et al. | — | 2001 | → |
| Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. | Noble EP | — | 2000 | → |
| A review of tobacco smoking in adolescents: treatment implications. | Moolchan ET et al. | — | 2000 | → |
| Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. | McKinney EF et al. | — | 2000 | → |
| Co-occurring risk factors for alcohol dependence and habitual smoking. | Bierut LJ et al. | — | 2000 | → |
| Epidemiology of tobacco carcinogenesis. | Shields PG | — | 2000 | → |
| Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. | Bierut LJ et al. | — | 2000 | → |
| Genetic risk factors for chronic obstructive pulmonary disease. | Sandford AJ et al. | — | 2000 | → |
| Haplotypes at the DRD2 locus and severe alcoholism. | Noble EP et al. | — | 2000 | → |
| Lung cancer chemoprevention. | Khuri FR et al. | — | 2000 | → |
| Polymorphisms in genes involved in neurotransmission in relation to smoking. | Arinami T et al. | — | 2000 | → |
| Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. | Blum K et al. | — | 2000 | → |
| Reward deficiency syndrome: genetic aspects of behavioral disorders. | Comings DE et al. | — | 2000 | → |
| The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment. | Lawford BR et al. | — | 2000 | → |
| The dopamine D2 receptor (DRD2) gene-a genetic risk factor in heavy smoking? | Batra A et al. | — | 2000 | → |
| The DRD2 gene in psychiatric and neurological disorders and its phenotypes. | Noble EP | — | 2000 | → |
| Brain event-related potentials, dopamine D2 receptor gene polymorphism, and smoking. | Anokhin AP et al. | — | 1999 | → |
| Cigarette smoking. | Bergen AW et al. | — | 1999 | → |
| Genetic studies of alcoholism and substance dependence. | Reich T et al. | — | 1999 | → |
| Multiple risk factors for the initiation of smoking: the public health imperative for multidisciplinary genetic epidemiological investigations of nicotine addiction. | Swan GE | — | 1999 | → |
| Myocardial stunning and dopamine receptor polymorphism. | Poullis M | — | 1999 | → |
| Non-traditional study designs in the analysis of gene-environment interactions. | Sobue T | — | 1999 | → |
| Overcoming barriers to nicotine dependence treatment. | Ferry LH | — | 1999 | → |
| Smoking behavior is under the influence of a major quantitative trait locus on human chromosome 5q. | Duggirala R et al. | — | 1999 | → |
| Cancer chemoprevention: progress and promise. | Lippman SM et al. | — | 1998 | → |
| D2 dopamine receptor and GABA(A) receptor beta3 subunit genes and alcoholism. | Noble EP et al. | — | 1998 | → |
| DRD2 gene and alcoholism. | Noble EP | — | 1998 | → |
| Scientific progress in understanding oral and pharyngeal cancers. | Winn DM et al. | — | 1998 | → |
| The DRD2 gene, smoking, and lung cancer. | Noble EP | — | 1998 | → |